Open Access · CC BY 4.0
Obesity and Atrial Fibrillation: Integrating Lifestyle, Pharmacotherapy and Ablation
Europace · 30.10.2026
DOI: 10.1093/europace/euag307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 30.10.2026. Verfasst von Francis J Ha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Heart Hospital, Clayton, Victoria, Australia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
atrial fibrillationmultidisciplinaryobesityrisk factorweight loss
Autor:innen und Institutionen
- Victorian Heart Hospital, Clayton, Victoria, Australia.
- Victorian Heart Institute, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Francis J Ha, Emily Kotschet, Nitesh Nerlekar
Zitieren
APA
Ha, F. J., Kotschet, E., & Nerlekar, N. (2026). Obesity and Atrial Fibrillation: Integrating Lifestyle, Pharmacotherapy and Ablation. Europace. https://doi.org/10.1093/europace/euag307
Vancouver
Ha FJ, Kotschet E, Nerlekar N. Obesity and Atrial Fibrillation: Integrating Lifestyle, Pharmacotherapy and Ablation. Europace. 2026. doi:10.1093/europace/euag307
BibTeX
@article{Ha2026,
author = {Ha, Francis J and Kotschet, Emily and Nerlekar, Nitesh},
title = {Obesity and Atrial Fibrillation: Integrating Lifestyle, Pharmacotherapy and Ablation},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag307}
}
EUVIMED